At Aspirar Medial Lab, we closely monitor each patient specimen throughout the testing life cycle until results are reviewed and reported to the physician. Results are available with our secure, HIPAA-compliant website, or other method requested.
We use Enzyme Immunoassay (EIA) to screen for the presence of a drug or metabolite. When positive on the EIA screen, the sample is sent to conﬁrmation for more speciﬁc analytical methods, if ordered by the physician. When this semi-quantitative test is positive, full confirmation is avaiable.
We are committed to our role in educating physicians on the requirement by OIG/HHS that all testing ordered must be deemed medically necessary. As part of our compliance plan , we offer fulldisclosure of the CPT codes we will bill with, along with the corresponding Medicare fees so that providers may consider those facts as they make their selections.
We offer cutting-edge resources for understanding the specific needs of patients based on their unique biochemistry. In addition, we have pharmacists on staff to answer any medicaiton questions.
As a convenience for the physicians and patients, we will pick up the samples at physician's medical office for test analysis. Resutls will be avaialble online or ingrated into practices EMR. Furthermore, testing supplies can be ordered through the lab.